INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer
Cancer Trials Ireland
Cancer Trials Ireland
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
University of Washington
Hoffmann-La Roche
AstraZeneca
M.D. Anderson Cancer Center
Proton Collaborative Group
NYU Langone Health
West Virginia University
Maastricht University Medical Center
Vanderbilt-Ingram Cancer Center
University of Wisconsin, Madison
Shanghai Pulmonary Hospital, Shanghai, China
University of Washington
Adaptimmune
Hoosier Cancer Research Network
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
University of Washington
Emory University
ChineseAMS
M.D. Anderson Cancer Center
Independent Public Care Health Facility of the Ministry of the Interior and Warmian & Mazurian Oncology Centre
Guizhou Medical University
M.D. Anderson Cancer Center
University of Washington
H. Lee Moffitt Cancer Center and Research Institute
Peking University People's Hospital
Hoosier Cancer Research Network
University of Kentucky
Stanford University
Trans Tasman Radiation Oncology Group
Trans Tasman Radiation Oncology Group
Clinical Oncology Research Associates
Clinical Oncology Research Associates
GlaxoSmithKline
International Atomic Energy Agency
Huazhong University of Science and Technology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)